[Validation of dissolution testing: evaluation of vibration levels of dissolution apparatuses]. 1998

N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
nkaniwa@nihs.go.jp

The collaborative study participated by seven laboratories was carried out to develop a dissolution standard for evaluating vibration levels of dissolution apparatuses using enteric-coated granules of cefalexin (EG). Dissolution apparatuses could be divided into two groups according to their vibration levels and the dissolution test results of EG by the rotating basket method at 50 rpm. The critical value of acceleration was about 0.05 m/s2. The upper limit of normal dissolution rates of EG was calculated from the results of the rotating basket method at 50 rpm obtained from low vibration apparatuses. All high vibration apparatuses used in this study were distinguished by the limit from low vibration apparatuses, although most of them were not distinguished by current USP calibrators. These results suggest that EG would be useful as a calibrator for detection of apparatuses on high vibration levels.

UI MeSH Term Description Entries
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013608 Tablets, Enteric-Coated Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed) Enteric-Coated Tablets,Tablets, Enteric Coated
D014732 Vibration A continuing periodic change in displacement with respect to a fixed reference. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Vibrations
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
August 2008, Journal of pharmaceutical sciences,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
February 1983, Journal of pharmaceutical sciences,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
October 1979, Journal of pharmaceutical sciences,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
January 2009, Journal of pharmaceutical sciences,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
January 2010, Journal of pharmaceutical sciences,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
April 1983, Die Pharmazie,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
December 2017, Molecular pharmaceutics,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
July 2017, AAPS PharmSciTech,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
January 2015, Polimery w medycynie,
N Kaniwa, and N Katori, and N Aoyagi, and S Kojima, and N Ishigame, and Y Seta, and T Shinba, and K Fujiwara, and T Nakai, and Y Oda
March 1989, Bulletin of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!